Public drug program spending in Canada by top 10 drug classes 2022
This statistic displays the total public drug program expenditures in Canada in the top 10 drug classes in 2022. During this year, HMG-CoA reductase inhibitors (statins), which are often used for treating high cholesterol, accounted for some 330 million Canadian dollars in public drug expenditures.
